Cortical Disarray Measurement (CDM) is a platform technology designed to assess Alzheimer’s disease at the cellular level, which is impossible to achieve with volumetric methods

We extract measurements directly from standard MRI/DTI data to provide an index linked to the micro-anatomical health of patients' brains

Our CDM software device provides unique insight into the point at which the disease materialises in the anatomy of the cerebral cortex

Our CDM Technology can identify the location and pattern of change in grey matter quality bringing a new level of diagnostic certainty beyond simple measures of quantity

Oxford Brain Diagnostics Ltd is a company registered in England and Wales. Registered No. 11703979 

Oxford Centre for Innovation, New Road, Oxford, OX1 1BY

VAT No. 321 3026 62